Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuronal "excitement" is not the name of a specific molecule, receptor, or therapeutic target. Instead, it refers to the physiological process by which neurons become more likely to fire action potentials in response to excitatory inputs. This process is mediated primarily by **excitatory neurotransmitters** such as glutamate and acetylcholine, which bind to their respective receptors on postsynaptic neurons and cause depolarization of the neuronal membrane[1][2][3][6]. The term encompasses a broad range of molecular mechanisms and does not correspond to a single protein or druggable entity. Dysfunction in excitatory signaling can contribute to various neurological and psychiatric diseases due to disrupted neural circuit activity[2][5]. Therefore, "neuronal excitement" should not be considered a canonical therapeutic target but rather describes an essential aspect of neural physiology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuronal excitement.